Basic information

Full name
phosphoinositide kinase, FYVE-type zinc finger containing
Ensembl
ENSG00000115020.17
Summary
Phosphorylated derivatives of phosphatidylinositol (PtdIns) regulate cytoskeletal functions, membrane trafficking, and receptor signaling by recruiting protein complexes to cell- and endosomal-membranes. Humans have multiple PtdIns proteins that differ by the degree and position of phosphorylation of the inositol ring. This gene encodes an enzyme (PIKfyve; also known as phosphatidylinositol-3-phosphate 5-kinase type III or PIPKIII) that phosphorylates the D-5 position in PtdIns and phosphatidylinositol-3-phosphate (PtdIns3P) to make PtdIns5P and PtdIns(3,5)biphosphate. The D-5 position also can be phosphorylated by type I PtdIns4P-5-kinases (PIP5Ks) that are encoded by distinct genes and preferentially phosphorylate D-4 phosphorylated PtdIns. In contrast, PIKfyve preferentially phosphorylates D-3 phosphorylated PtdIns. In addition to being a lipid kinase, PIKfyve also has protein kinase activity. PIKfyve regulates endomembrane homeostasis and plays a role in the biogenesis of endosome carrier vesicles from early endosomes. Mutations in this gene cause corneal fleck dystrophy (CFD); an autosomal dominant disorder characterized by numerous small white flecks present in all layers of the corneal stroma. Histologically, these flecks appear to be keratocytes distended with lipid and mucopolysaccharide filled intracytoplasmic vacuoles. Alternative splicing results in multiple transcript variants encoding distinct isoforms.[provided by RefSeq, May 2010]

Protein product

Phosphosites on the primary protein product
Loading...

Tumor and normal comparison

Loading, please wait
Signed p-values
Data type
Meta P
BRCA
CCRCC
COAD
GBM
HNSCC
LSCC
LUAD
OV
PDAC
UCEC
RNA-1.3e-19--1.2e-12---0.72-0.14-2.5e-14--2.1e-4-
protein-1.1e-11--1.3e-6---0.8-3.6e-6-6.4e-110.15-0.37-0.023

* P-values are from Wilcoxon rank sum test and can be clicked to show the box plots. Positive values mean higher abundance in tumor. BRCA and GBM do not have normal samples.

mRNA expression at gene level
BRCACCRCCCOADGBMHNSCCLSCCLUADOVPDACUCEC77.588.599.51010.51111.51212.51313.5log2(RSEM+1)tumornormal
Protein expression
BRCACCRCCCOADGBMHNSCCLSCCLUADOVPDACUCEC16171819202122232425log2(MS1 intensity)tumornormal

* Mild outlier: filled circle; Extreme outlier: empty circle.

Phenotype and mutation association

Manhattan plot summarizing associations of phenotypes and mutations across all cohorts and omics data types

BRCACCRCCCOADGBMHNSCCLSCCLUADOVPDACUCEC02468101214160-2-4-6-8-10-12-14-16Pan-cancer0510152025303540450-5-10-15-20-25-30-35-40-45proteinRNASCNVclinicalpathwaycell typegenomicmutation-log10 of P-value

* Data points of significant associations above and below the dotted lines can be hovered to show the phenotype.

Associations of the protein abundance of PIKFYVE with phenotypes and mutations

Loading, please wait
Signed p-values
Phenotype
Meta P
BRCA
CCRCC
COAD
GBM
HNSCC
LSCC
LUAD
OV
PDAC
UCEC
xcell: Myeloid dendritic cell5.1e-81.2e-39.6e-40.43-0.20.0791.6e-40.0150.210.20.5
xcell: T cell CD8+ central memory1.6e-71.4e-30.220.45-0.0130.0273.9e-43.4e-30.0160.540.033
xcell: Myeloid dendritic cell activated4.2e-70.0330.420.72-0.550.0241.3e-60.0290.090.011-0.84
HALLMARK_IL2_STAT5_SIGNALING1.2e-63.7e-40.10.57-5.9e-100.032.4e-69.1e-60.680.0130.11
xcell: T cell CD4+ memory1.3e-60.050.21-0.84-0.0530.147.6e-33.8e-41.6e-40.260.11
xcell: immune score1.5e-61.6e-36.9e-30.28-1.4e-96.5e-32.5e-64.8e-40.0470.410.55
ESTIMATE: ImmuneScore1.5e-61.3e-40.090.47-1.6e-97.2e-33e-76.1e-50.160.220.58
xcell: B cell plasma1.7e-60.160.440.441.5e-30.148.3e-30.270.130.390.16
xcell: Class-switched memory B cell1.8e-60.0130.0410.68-0.144.6e-45.3e-60.0210.16-1-0.88
PROGENy: Trail3.6e-68.7e-30.170.19-2.2e-33.8e-38.2e-78.3e-40.210.35-0.33
Showing 1 to 10 of 256 rows

* P-values could be from test for Spearman correlation, Wilcoxon rank sum test, Jonckheere-Terpstra trend test or Cox regression depending on the data type. P-values for individual cohorts can be clicked to show the data plots. The matrix icons in each row can be clicked to show a heatmap summary of associations across all cohorts and omics. The rows in the table can be expanded to show results from other omics.

Cis-association

Associations between omics data of PIKFYVE

BRCA0.220.190.34proteinmRNASCNVmethylationCCRCC0.640.030.440.110.460.17proteinmRNASCNVmethylationCOAD0.010.310.20proteinmRNASCNVmethylationGBM0.69-0.000.290.180.330.09proteinmRNASCNVmethylationHNSCC0.49-0.070.35-0.140.61-0.05proteinmRNASCNVmethylationLSCC0.620.000.33-0.040.430.02proteinmRNASCNVmethylationLUAD0.510.100.380.020.650.03proteinmRNASCNVmethylationOV0.140.240.20proteinmRNASCNVmethylationPDAC0.210.000.18-0.060.380.03proteinmRNASCNVmethylationUCEC0.630.060.310.090.27-0.01proteinmRNASCNVmethylation

* The numbers are Spearman correlation coefficients and can be clicked to show the scatter plots. The color and size of the circles correlate with the coefficients.

Trans-association

Associations of the protein abundance of PIKFYVE and the protein abundance of other genes

Loading, please wait
Signed p-values
Gene
Meta P
BRCA
CCRCC
COAD
GBM
HNSCC
LSCC
LUAD
OV
PDAC
UCEC
No matching records found

* P-values are from test for Spearman correlation. P-values for individual cohorts can be clicked to show the data plots. The matrix icons in each row can be clicked to show a heatmap summary of associations across all cohorts and omics. The rows in the table can be expanded to show results from other omics.

Gene set enrichment analysis

Submit genes and the common logarithm of the p-values of their association with to WebGestalt.